Ligand validation:8H8S

LFA: EICOSANE

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8H8S_LFA_P_309	24%	94%	0.213	0.861	0.22	0.23	-	-	5	0	90%	0.36
8H8S_LFA_N_606	24%	89%	0.244	0.927	0.34	0.31	-	-	5	0	70%	0.42
8H8S_LFA_C_309	23%	91%	0.207	0.845	0.27	0.29	-	-	6	0	90%	0.36
8H8S_LFA_O_302	19%	92%	0.248	0.87	0.26	0.26	-	-	1	0	85%	0.51
8H8S_LFA_A_607	18%	91%	0.279	0.918	0.34	0.25	-	-	3	0	70%	0.42
8H8S_LFA_P_312	16%	91%	0.264	0.878	0.38	0.19	-	-	0	0	75%	0.45
8H8S_LFA_C_315	16%	96%	0.21	0.839	0.21	0.17	-	-	4	0	65%	0.39
8H8S_LFA_P_313	14%	92%	0.261	0.88	0.33	0.2	-	-	3	0	65%	0.39
8H8S_LFA_T_104	13%	96%	0.231	0.854	0.18	0.16	-	-	0	0	55%	0.33
8H8S_LFA_B_307	10%	94%	0.301	0.84	0.27	0.17	-	-	1	0	85%	0.51
8H8S_LFA_C_314	9%	86%	0.275	0.804	0.29	0.43	-	-	3	0	75%	0.45
8H8S_LFA_O_303	6%	96%	0.277	0.782	0.21	0.14	-	-	4	0	55%	0.33
8H8S_LFA_C_310	6%	97%	0.402	0.873	0.19	0.13	-	-	1	0	75%	0.3
8H8S_LFA_C_312	5%	94%	0.324	0.79	0.33	0.11	-	-	0	0	70%	0.35
8H8S_LFA_T_103	5%	97%	0.327	0.792	0.21	0.11	-	-	4	0	70%	0.35
8H8S_LFA_P_310	5%	98%	0.326	0.806	0.13	0.12	-	-	3	0	55%	0.275
8H8S_LFA_N_607	4%	84%	0.279	0.714	0.42	0.34	-	-	5	0	70%	0.42
8H8S_LFA_P_311	4%	92%	0.389	0.852	0.3	0.22	-	-	6	0	55%	0.275
8H8S_LFA_C_307	3%	98%	0.424	0.851	0.14	0.14	-	-	2	0	55%	0.22
8H8S_LFA_C_311	3%	97%	0.36	0.783	0.22	0.11	-	-	1	0	55%	0.275
8H8S_LFA_C_313	3%	97%	0.388	0.809	0.19	0.13	-	-	2	0	55%	0.275
8H8S_LFA_T_101	3%	74%	0.297	0.675	0.66	0.36	-	-	6	0	70%	0.42
8H8S_LFA_C_325	2%	96%	0.445	0.8	0.22	0.15	-	-	4	0	75%	0.3
8H8S_LFA_C_308	1%	97%	0.546	0.774	0.23	0.08	-	-	0	0	30%	12
8H8S_LFA_P_307	0%	93%	0.427	0.572	0.23	0.26	-	-	1	0	55%	0.22
8H8S_LFA_P_308	0%	98%	0.568	0.757	0.19	0.09	-	-	0	0	30%	12
8H8R_LFA_C_309	31%	95%	0.194	0.878	0.22	0.19	-	-	10	0	90%	0.36
7COH_LFA_C_716	28%	97%	0.152	0.821	0.17	0.16	-	-	3	0	90%	0.36
6SU4_LFA_X_616	66%	100%	0.113	0.917	0.09	0.1	-	-	0	0	100%	1
7AKY_LFA_A_403	58%	99%	0.088	0.911	0.08	0.14	-	-	5	0	75%	0.75
8QLF_LFA_A_408	56%	100%	0.083	0.933	0.1	0.06	-	-	1	0	55%	0.55
6RF6_LFA_A_307	50%	79%	0.101	0.904	0.23	0.62	-	-	0	0	70%	0.7
4HYJ_LFA_B_302	48%	74%	0.164	0.962	0.2	0.79	-	-	1	0	70%	0.7

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.